Eurozyto GmbH – Trademark Portfolio

Entity Type: 16

Eurozyto GmbH holds 10 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 10 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include EUROZYTO and EURONUTRIX. The owner is based in Königstein.

Limburger Straße 50

Königstein 61462 , DE

10 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Eurozyto GmbH's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (10 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (9 filings)

Surgical, medical, dental and veterinary apparatus and instruments

1
Chemicals (7 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Eurozyto GmbH have?

Eurozyto GmbH has 10 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Eurozyto GmbH file in?

Eurozyto GmbH files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 1 (Chemicals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Eurozyto GmbH's most well-known trademarks?

Eurozyto GmbH's registered trademark portfolio includes well-known marks such as EUROZYTO and EURONUTRIX. These are among 2 currently registered trademarks in the portfolio.

What is Eurozyto GmbH's trademark registration success rate?

Eurozyto GmbH has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.